NCT07776262
Safety and Efficacy of Cryoablation for Thyroid Tumors
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Tumor Volume Reduction Rate (VRR) at 12 months after ablation
Timeframe: Baseline (pre-ablation), 12 months after ablation
Secondary (4)
Complete tumor disappearance rate at 12 months
Incidence of treatment-related complications
Postoperative pain visual analog scale (VAS) score
Total operation time
Arms and interventions
Microwave Ablation GroupActive comparator
Patients receive conventional ultrasound-guided microwave ablation.
Cryoablation GroupExperimental
Participants undergo ultrasound-guided cryoablation, the investigational treatment evaluated in this study.
Procedures: Ultrasound-guided percutaneous cryoablation of thyroid neoplasm, Ultrasound-guided percutaneous microwave ablation of thyroid neoplasm
Sites
1 site in 1 country
- Chinese People's Liberation Army General HospitalBeijing, Beijing Municipality, China